Compare Brookfield Renewable (BEP) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brookfield Renewable vs Revvity Inc — how do they compare? Brookfield Renewable trades at $28.94 (market cap $8.43B), while Revvity Inc trades at $156.34 (market cap $17.48B). The key difference: Revvity Inc is far larger — about 2.1× Brookfield Renewable's market cap, and Brookfield Renewable pays the higher dividend (5.55%). Which is the better fit depends on your goals — on Pluang, investors hold Brookfield Renewable for 15 Days and Revvity Inc for 13 Days on average.
| BEP | RVTY | |
|---|---|---|
Market Cap | $8.43B | $17.48B |
Volume | 660,669 | 1,995,290 |
Sector | Utilities | Health |
52-Week High | $37.31 | $157.36 |
52-Week Low | $26.67 | $82.26 |
Typical Hold Time | 15 Days | 13 Days |
Enterprise Value | $43.03B | $19.79B |
Dividend Yield | 5.55% | 0.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BEP trades at $28.23, up 0.28% on the day, amid a bearish technical signal with moving averages indicating selling pressure. The company reported a net loss of $37 million in 2025, with negative profit margins and ROE, though revenue remains stable at $6.41 billion. Recent news highlights corporate simplification efforts and expansion into AI-driven energy demand.
Analyst consensus is bullish with a $37.83 price target, but fundamental weakness and recent earnings misses pose risks. The stock's high P/E of 61.37 suggests premium valuation despite profitability challenges, requiring careful monitoring of upcoming Q3 2026 results for turnaround signs.
RVTY trades at $156.01, up 3.36% on the day and near its 52-week high of $158.28. The stock shows strong technical momentum with bullish moving averages and support at $153. Fundamentally, the company reported consistent earnings beats in recent quarters, with Q3 2026 results due November 3. Revenue remains stable around $2.9B, though net income margin dipped slightly to 8.16% in 2026. Recent news highlights product launches in Europe and an acquisition to expand metabolic disease research tools.
Outlook is positive with analyst consensus leaning Buy (51.72%) and a price target of $132.13, though current price exceeds the target. Key opportunities include diagnostics growth and AI-driven demand, while risks involve China market pressures and rich valuation (P/E 75.29). Earnings growth and execution on strategic acquisitions are critical for sustaining momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Brookfield Renewable
Brookfield Renewable owns and operates renewable power and sustainable solutions businesses. Its portfolio includes hydroelectric, wind, solar, distributed energy, and energy storage assets.
Read more on BEP →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
